Literature DB >> 10584971

Age-dependent pathways of brain energy metabolism: the suckling rat, a natural model of the ketogenic diet.

A Nehlig1.   

Abstract

As a consequence of the high fat content of maternal milk, the suckling rat may be viewed as a 'natural model' of the ketogenic diet. Changes in energy metabolism during this period of development may give us some clues into the antiepileptic properties of the ketogenic diet. We have, therefore studied the postnatal evolution of local cerebral metabolic rates for glucose (LCMRglcs) and of regional rates of cerebral uptake of beta-hydroxybutyrate (betaHB) in the developing rat between postnatal day (PN) 10 and 35. LCMRglcs were low and homogeneous at PN10. They increased significantly in four auditory regions between PN10 and PN14, at the time of maturation of auditory function. Between PN14 and PN17, they increased further in two auditory regions, one visual area (the lateral geniculate nucleus), three limbic and three motor areas. These increases occurred simultaneously with the maturation of vision and the development of locomotion and general exploratory behavior. Between PN17 and PN21, LCMRglcs increased by 28-97% (depending on brain area) and by a mean value of 25% in all areas studied. In contrast to the function-related increases in LCMRglcs, regional rates of cerebral betaHB uptake underwent a generalized non-specific increase between PN1O and PN14, and stayed at a high level until PN17. Between PN17 and PN21, rates of cerebral betaHB uptake decreased significantly in all brain regions studied, and reached very low levels by PN35. Thus, even in the suckling rat, whose cerebral metabolic activity depends upon both glucose and ketone bodies, it is the postnatal increases in LCMRglcs that appear to be critical for the acquisition of new functions and neurological competence. Conversely, the homogeneous increase in cerebral betaHB uptake occurring between PN10 and PN17 at a period of active brain growth may rather reflect non-specific mechanisms of cell growth.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10584971     DOI: 10.1016/s0920-1211(99)00073-x

Source DB:  PubMed          Journal:  Epilepsy Res        ISSN: 0920-1211            Impact factor:   3.045


  13 in total

Review 1.  Ketone bodies in epilepsy.

Authors:  Melanie A McNally; Adam L Hartman
Journal:  J Neurochem       Date:  2012-02-07       Impact factor: 5.372

2.  Obligate role for ketone body oxidation in neonatal metabolic homeostasis.

Authors:  David G Cotter; D André d'Avignon; Anna E Wentz; Mary L Weber; Peter A Crawford
Journal:  J Biol Chem       Date:  2011-01-05       Impact factor: 5.157

3.  Substrate competition studies demonstrate oxidative metabolism of glucose, glutamate, glutamine, lactate and 3-hydroxybutyrate in cortical astrocytes from rat brain.

Authors:  Mary C McKenna
Journal:  Neurochem Res       Date:  2012-10-19       Impact factor: 3.996

Review 4.  Ketone bodies, glycolysis, and KATP channels in the mechanism of the ketogenic diet.

Authors:  Gary Yellen
Journal:  Epilepsia       Date:  2008-11       Impact factor: 5.864

5.  Selective astrocytic gap junctional trafficking of molecules involved in the glycolytic pathway: impact on cellular brain imaging.

Authors:  Gautam K Gandhi; Nancy F Cruz; Kelly K Ball; Sue A Theus; Gerald A Dienel
Journal:  J Neurochem       Date:  2009-05-15       Impact factor: 5.372

6.  Augmented cerebellar lactate in copper deficient rat pups originates from both blood and cerebellum.

Authors:  Anna A Gybina; Joseph R Prohaska
Journal:  Metab Brain Dis       Date:  2009-03-25       Impact factor: 3.584

Review 7.  Harnessing the power of metabolism for seizure prevention: focus on dietary treatments.

Authors:  Adam L Hartman; Carl E Stafstrom
Journal:  Epilepsy Behav       Date:  2012-10-27       Impact factor: 2.937

Review 8.  Neuroketotherapeutics: A modern review of a century-old therapy.

Authors:  Scott J Koppel; Russell H Swerdlow
Journal:  Neurochem Int       Date:  2017-06-01       Impact factor: 3.921

9.  The ketogenic diet as a treatment paradigm for diverse neurological disorders.

Authors:  Carl E Stafstrom; Jong M Rho
Journal:  Front Pharmacol       Date:  2012-04-09       Impact factor: 5.810

10.  Supragranular Pyramidal Cells Exhibit Early Metabolic Alterations in the 3xTg-AD Mouse Model of Alzheimer's Disease.

Authors:  Juliette Piquet; Xavier Toussay; Régine Hepp; Rodrigo Lerchundi; Juliette Le Douce; Émilie Faivre; Elvire Guiot; Gilles Bonvento; Bruno Cauli
Journal:  Front Cell Neurosci       Date:  2018-07-18       Impact factor: 5.505

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.